Safety, Pharmacokinetics, and Efficacy of AI-081, a Bispecific Antibody for PD-1 And VEGF in Advanced Solid Tumors

Inclusion Criteria: * Patient is ≥ 18 years of age on the day of signing informed consent. * Male or female, female patient of childbearing potential must have negative pregnancy test. * Patient must have a performance status of ≤ 1 on the ECOG Performance Scale. * Patients must have a histological or cytological diagnosis of solid tumors and have metastatic disease or locally advanced disease. * Measurable disease as determined by RECIST 1.1 * Patient must have adequate organ function as indicated by the following laboratory values * Patient has voluntarily agreed to participate by giving wr…